Iovance Biotherapeutics
Jennifer Anderson is the Manager of Quality Operations at Iovance Biotherapeutics, Inc., where Jennifer leads the quality operations floor support staff for cGMP cell therapy manufacturing. Jennifer reviews and approves manufacturing batch records, collaborates with external quality for CMO products, and provides compliance feedback on protocols. With prior experience at the University of Pennsylvania and Merck, Jennifer has a strong background in microbiology, environmental monitoring, and quality control. Jennifer holds a Master of Engineering in Biotechnology from the University of Pennsylvania.
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.